S2Medical AB (publ) signs exclusive distribution agreement for the Qatari market

S2Medical AB (publ) has signed an exclusive distribution agreement for the Qatari market with Wesburry Trading. The agreement covers all products that are represented by S2Medical in the region and implies initial orders of about 250 000 SEK as well as commitments to further orders of at least 8 million SEK over the coming 3 years to keep the validity of the agreement. Wesburry Trading is a large distribution company in Qatar that represent many known brands within several categories of medical products.

”Qatar has been one of few countries in the GCC region where our products haven’t been represented by a distributor. We are therefore very happy to have signed this agreement with a large and well-known distributor in the country. Given Wesburry’s close cooperation with the country’s by far largest care provider, Hamad Medical Corporation, we see a potential for a rapid start of the sales of our products” says the company’s COO Mårten Skog who is responsible for the company’s operations in the Middle East.

This disclosure contains information that S2Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 26-07-2022 09:11 CET.

Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se

Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se 
E-mail: ca@vatorsec.se

About S2Medical 

S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.

Share's ticker: S2M

Share's ISIN-code: SE0011725084